Key Points
- Major shareholder John Gottwald sold 19,408 Tredegar shares on Feb. 10 at an average price of $9.13 for about $177,195, reducing his position by 3.03% to 621,584 shares (≈$5.675M).
- Tredegar shares trade around $9.03 with a market cap of $315.2M, a negative P/E of -5.71, 50‑day/200‑day moving averages of $8.02/$7.86, and a 52‑week range of $6.25–$9.43.
- Institutional investors own about 79.24% of the company, and analyst coverage is mixed but shows a consensus rating of "Sell" (Weiss: sell; Wall Street Zen: strong-buy).
Tredegar Corporation (NYSE:TG - Get Free Report) major shareholder John Gottwald sold 19,408 shares of the company's stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $9.13, for a total transaction of $177,195.04. Following the completion of the sale, the insider owned 621,584 shares in the company, valued at approximately $5,675,061.92. This trade represents a 3.03% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.
Tredegar Trading Down 0.1%
NYSE TG opened at $9.03 on Friday. The company has a 50-day moving average price of $8.02 and a two-hundred day moving average price of $7.86. The stock has a market cap of $315.20 million, a price-to-earnings ratio of -5.71 and a beta of 0.65. Tredegar Corporation has a 52 week low of $6.25 and a 52 week high of $9.43.
Institutional Trading of Tredegar
Several large investors have recently made changes to their positions in TG. Russell Investments Group Ltd. lifted its position in Tredegar by 531.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 3,376 shares of the basic materials company's stock worth $27,000 after acquiring an additional 2,841 shares during the last quarter. Torren Management LLC acquired a new stake in Tredegar in the 4th quarter valued at approximately $32,000. BNP Paribas Financial Markets increased its position in Tredegar by 53.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 5,273 shares of the basic materials company's stock worth $42,000 after buying an additional 1,830 shares during the period. Tower Research Capital LLC TRC lifted its holdings in shares of Tredegar by 225.3% during the second quarter. Tower Research Capital LLC TRC now owns 6,889 shares of the basic materials company's stock worth $61,000 after buying an additional 4,771 shares during the last quarter. Finally, Citadel Advisors LLC raised its stake in Tredegar by 163.7% during the 3rd quarter. Citadel Advisors LLC now owns 11,850 shares of the basic materials company's stock valued at $95,000 after purchasing an additional 30,450 shares during the last quarter. Institutional investors own 79.24% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have issued reports on TG shares. Weiss Ratings restated a "sell (d-)" rating on shares of Tredegar in a report on Wednesday, January 21st. Wall Street Zen raised Tredegar from a "hold" rating to a "strong-buy" rating in a research note on Saturday, November 15th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of "Sell".
Check Out Our Latest Stock Analysis on Tredegar
Tredegar Company Profile
(
Get Free Report)
Tredegar Corporation is a diversified manufacturer specializing in high-performance plastic films and aluminum extrusions. Headquartered in Richmond, Virginia, the company operates through two primary segments—Films and Manufactured Products—serving a broad range of industries that include flexible packaging, medical devices, electronics, building and construction. Tredegar's operations focus on delivering tailored solutions that meet demanding specifications for barrier properties, film strength and extrusion tolerances.
The Films segment produces a variety of polyolefin films, including cast and blown polyethylene, BOPP (biaxially oriented polypropylene), barrier films and specialty medical-grade films.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
